1 Min Read
Jan 3 (Reuters) - Quest Pharmatech Inc:
* QUEST PHARMATECH- UNIT SIGN EXCLUSIVE LICENSE AGREEMENT WITH STANFORD UNIVERSITY TO DEVELOP & COMMERCIALIZE PATENTED EGF WOUND HEALING TECHNOLOGY Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.